This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

GlaxoSmithKline PLC (GSK)

NYSE: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 6.75B 9.13B 6.76B 8.87B
Receivables 6.92B 8.71B 8.64B 8.79B
Inventories 6.59B 6.43B 6.41B 6.01B
Other Current Assets 2.03B 257.24M 182.61M 1.14B
Total Current Assets 22.85B 25.11B 22.13B 25.10B
Property, Plant & Equipment, Gross 29.39B 31.09B 30.29B 29.24B
Accumulated Depreciation & Depletion 15.30B 16.46B 16.11B 15.66B
Property, Plant & Equipment, Net 14.09B 14.63B 14.18B 13.58B
Intangibles 12.95B 15.31B 16.42B 12.11B
Other Non-Current Assets 3.41B 3.98B 3.40B 2.73B
Total Non-Current Assets 40.43B 44.29B 44.90B 38.68B
Liabilities & Shareholder Equity
Total Assets 63.27B 69.40B 67.02B 63.78B
Accounts Payable 4.81B 8.83B 13.02B 11.43B
Short Term Debt 4.58B 4.60B 5.87B 4.19B
Other Current Liabilities 4.03B 4.24B 3.44B 7.69B
Total Current Liabilities 20.69B 22.55B 22.33B 23.30B
Long Term Debt 24.66B 25.49B 23.71B 18.95B
Deferred Income Taxes 692.63M 1.14B 1.62B 1.28B
Other Non-Current Liabilities 9.55B 7.33B 8.46B 6.55B
Minority Interest 116.74M 316.61M 289.26M 305.86M
Total Non-Current Liabilities 35.94B 35.31B 35.31B 28.01B
Total Liabilities 56.64B 57.86B 57.63B 51.31B
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 6.64B 11.54B 9.39B 12.47B
Common Par 2.08B 2.20B 2.18B 2.15B
Additional Paid In Capital 4.29B 4.28B 3.27B 2.60B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -3.23B 1.51B 1.05B 5.23B
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 3.48B 3.55B 2.89B 2.49B
Total Capitalization 31.29B 37.02B 33.10B 31.42B
Total Equity 6.64B 11.54B 9.39B 12.47B
Total Liabilities & Stock Equity 63.27B 69.40B 67.02B 63.78B
Total Common Shares Outstanding 2.68B 2.43B 2.45B 2.52B
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 491.52M 487.43M 494.95M 501.20M
Basic Weighted Shares Outstanding 2.40B 2.42B 2.46B 2.51B
Diluted Weighted Shares Outstanding 2.43B 2.46B 2.49B 2.56B
Number of Employees 97921 99451 99488 97389
Number of Part-Time Employees 0 0 0 0
GSK News

GSK GlaxoSmithKline PLC

Analysts Ratings for GSK

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 1 1
Moderate Buy 0 0 0 0
Hold 5 4 5 5
Moderate Sell 1 1 1 1
Strong Sell 0 0 1 1
GET GSK ANALYST REPORT

Brokerage Partners

GSK Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs